To provide an updated review on the clinical experience in laparoscopic liver resection, specifically for hepatocellular carcinoma. METHODS: A comprehensive literature search in MEDLINE was conducted for all English papers up to May 2010 on laparoscopic liver resection for hepatocellular carcinoma. Patient characteristics, perioperative results, and oncologic outcomes were compared and analysed. RESULTS: We analysed 11 clinical studies involving 466 hepatocellular carcinoma patients treated with laparoscopic hepatectomy. Thirty-seven (9%) patients underwent major resection. Cirrhosis occurred in 62%. The mean operative time was 189.5 min, and the mean blood loss was 315.6 mL. Blood transfusion was required in 14.6% of patients. There were two operative deaths. Postoperative complications included bile leakage (1%), bleeding (2.9%), liver failure (5.1%), and ascites (6%). The 1-year, 3-year, and 5-year diseasefree survival rates ranged from 60% to 90%, 50% to 64%, and 31% to 50%, respectively, and the corresponding overall survival rates ranged from 85% to 100%, 67% to 100%, and 50% to 97% respectively. CONCLUSION: Laparoscopic liver resection for hepatocellular carcinoma appears to be safe and to achieve acceptable oncologic outcomes even in cirrhotic livers, but whether it is comparable to conventional open surgery needs to be evaluated in a randomized, controlled trial setting. [Asian J Surg 2010;33(4):168-72] 
Introduction
Laparoscopic resection of liver tumours was first reported in 1993. 1 It was initially adopted to treat peripheral, benign tumours amenable to nonanatomical wedge resection. The relatively slow development of laparoscopic liver resection compared with that of other subspecialties of laparoscopic surgery can be attributed to several reasons. First, some technical manoeuvres frequently applied in open liver resection, such as organ mobilization, control of vascular inflow, and hanging manoeuvres, are difficult to reproduce in the laparoscopic setting. Difficulty in controlling haemorrhage, especially when profuse bleeding arises from the inferior vena cava or occurs deep in the liver parenchyma, is another major concern. Risk of gas embolism secondary to pneumoperitoneum could lead to dire consequences. In addition, increased risks of postoperative bile leakage and bleeding and uncertain long-term oncologic outcomes concomitant with resection of malignant tumours are all obstacles that have undermined the development of laparoscopic hepatectomy.
With advancement in surgical instruments and increasing experience in laparoscopic treatment for benign liver diseases, there has been a growing interest in its application for hepatocellular carcinoma (HCC). The Louisville consensus statement 2 concluded that left lateral sectionectomy should be performed routinely by the laparoscopic approach. In the world review of over 2,000 laparoscopic liver resections, 1 postoperative morbidity and mortality were shown to be comparable with those of open resection for both benign and malignant diseases. Nonetheless, disease heterogeneity among these reviewed studies render interpretation of surgical outcomes to specific indications difficult. HCC is a common malignancy in the East Asia due to the prevalence of hepatitis B infection. Cirrhosis is a known risk factor for the development of HCC, and major hepatectomy for cirrhotic livers could be technically challenging, even by an open approach. The aim of this article was to review the global experience of laparoscopic resection for HCC, especially in cirrhotic livers.
Patients and methods
A comprehensive literature search in MEDLINE using the keywords "laparoscopic liver resection" and "hepatocellular carcinoma" was performed up to May 2010. English articles with human subjects were selected. Small series (i.e. < 15 patients) and case reports were excluded. A total of 155 publications were identified. All papers were screened and apparent duplicate data were excluded. Eleven papers [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] with ≥ 15 patients per study were selected. and inadequate resection margins. 4 
Intraoperative outcomes
More than half of the major resections were left (7/37) or right (12/37) hemihepatectomies (Table 3 3-13 ). Central bisectionectomy 4 and trisectionectomy 11 were seldom per- attributed by the greater proportion of major hepatectomies in their studies (13% and 15%, respectively). The mean blood loss was 315.6 mL. None of the studies reported a mean blood loss of over 1 L (103-808 mL). However, blood transfusion was required in 14.6% of the cases (Table 4 3-13
).
Postoperative outcomes Mortality
There were two operative deaths among the 466 patients. One death was due to severe respiratory distress syndrome, and the patient died 3 days after the operation. 
Morbidity
Morbidity was difficult to compare between the studies because of the heterogenicity in the reporting methods. However, we selected the clinically significant postoperative morbidities (bile leakage, bleeding, liver failure, and ascites) for analysis. The results are shown in Table 5 .
3-13
Postoperative bleeding occurred in 2.9% of the patients, liver failure in 5.1%, ascites in 6%, and bile leakage in 1%. The incidence of these postoperative morbidities appeared to be comparable with those in open resections. [14] [15] [16] After open hepatectomy for cirrhotic livers, early formation of ascites could leak through the healing wound, which is psychologically disturbing to patients and could predispose to wound infection. The adoption of laparoscopic surgery would certainly minimize such negative effects of ascites.
The average length of hospital stay was 9 days. However, length of hospital stay is not a reliable indicator of postoperative outcome because it can differ across different cultures and hospital policies. A better indicator would be the time to resume a full diet, but this was only reported in the Chen et al study, 10 on postoperative days 2-3. Oncologic outcomes and survival Table 6 3-8,10-13 illustrates the long-term survival rates of all selected studies. Tumour size ranged from 2.3 to 4.7 cm. Resection margin was reported in most of the studies, but was usually quoted as > 1 cm; thus, there was a lack of quantitative data to allow for comparison. The average time for the development of tumour recurrence ranged from 5 to 13 months. There was no incidence of port site metastasis. The 1-year, 3-year, and 5-year diseasefree survival rates ranged from 60% to 90%, 50% to 64%, and 31% to 50%, respectively. The 1-year, 3-year, and 5-year overall survival rates ranged from 85% to 100%, 67% to 100%, and 50% to 97%, respectively.
Conclusion
The future direction of laparoscopic liver resection will be the use of surgical robotic systems. 1, 17, 18 Cases of liver resection with the use of the Da Vinci robotic system have been reported. 19 Potential advantages of using robots include visualization of high-quality three-dimensional images and tremor-filtering. EndoWrist, a robotic instrument, even provides a 360-degree range of motion. However, the advantages of employing robotic systems must be balanced with the entailed high cost of surgery, lack of training schemes, and difficulty of conversion to open surgery. Nonetheless, the use of surgical robots is expected to become more common in the treatment of both benign and malignant liver tumours in the foreseeable future. Laparoscopic liver resection has proven to be a safe and feasible treatment option for HCC, even in cirrhotic livers. Conversion, however, does not equate to failure. With advances in surgical techniques and instruments, laparoscopic liver resection is performed more frequently, even for tumours in difficult anatomical locations. Nonetheless, oncologic clearance should not be jeopardized in exchange for the postoperative benefits of laparoscopic surgery. Although laparoscopic liver resection seems to achieve acceptable long-term survival outcomes, whether it is comparable to conventional open surgery must be evaluated in a randomized, controlled trial setting. 
